ConditionKidney Rejection Transplant
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorParis Translational Research Center for Organ Transplantation
About this trial
Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better understand the pathophysiological mechanisms associated with the various phenotypes of microvascular inflammation that are observed in kidney transplants, particularly in order to develop targeted therapeutic approaches.
Eligibility criteria
Qualifiers
None
Disqualifiers
Inadequate biopsy according to the Banff classification
Missing data for Banff lesion scores, donor-specific antibody status, C4d staining
Biopsies showing histological signs of ischemia-reperfusion
Combined transplantation and kidney transplantation after a non-kidney solid organ transplantation
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov